Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
James Nyagwange
Observed names:
J Nyagwange,
J. Nyagwange,
James N. Nyagwange,
Nyagwange, James
Institutions:
Kenya Medical Research Institute,
KEMRI-Wellcome Trust Research Programme,
Wellcome Trust
Observed institutions:
The Pirbright Institute,
Kenya Medical Research Institute,
KEMRI-Wellcome Trust Research Programme,
International Livestock Research Institute,
Wellcome Trust,
Wageningen University & Research
show all 6
ORCID:
0000-0001-5430-6011
Observed ORCID:
0000-0001-5430-6011
OpenAlex ID:
A5083853693
Seroprevalence of anti–SARS-CoV-2 IgG antibodies in Kenyan blood donors
2020
·
Sophie Uyoga
, Ifedayo M.O. Adetifa
, et al.
·
Science
·
327
COVID-19 transmission dynamics underlying epidemic waves in Kenya
2021
·
Samuel P. C. Brand
, John Ojal
, et al.
·
Science
·
88
Temporal trends of SARS-CoV-2 seroprevalence during the first wave of the COVID-19 epidemic in Kenya
2021
·
Ifedayo M. O. Adetifa
, Sophie Uyoga
, et al.
·
Nature Communications
·
67
PDF
Prevalence of SARS-CoV-2 Antibodies From a National Serosurveillance of Kenyan Blood Donors, January-March 2021
2021
·
Sophie Uyoga
, Ifedayo M.O. Adetifa
, et al.
·
JAMA
·
48
PDF
Seroprevalence of Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 Among Healthcare Workers in Kenya
2021
·
Anthony O Etyang
, Ruth Lucinde
, et al.
·
Clinical Infectious Diseases
·
45
PDF
Sero-surveillance for IgG to SARS-CoV-2 at antenatal care clinics in three Kenyan referral hospitals: Repeated cross-sectional surveys 2020–21
2022
·
R. Lucinde
, D. Mugo
, et al.
·
PLoS ONE
·
35
Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Immunoglobulin G Antibody Seroprevalence Among Truck Drivers and Assistants in Kenya
2021
·
E Wangeci Kagucia
, John N Gitonga
, et al.
·
Open Forum Infectious Diseases
·
32
PDF
Quantifying previous SARS-CoV-2 infection through mixture modelling of antibody levels
2021
·
C. Bottomley
, M. Otiende
, et al.
·
Nature Communications
·
31
PDF
SARS-CoV-2 seroprevalence in three Kenyan health and demographic surveillance sites, December 2020-May 2021
2022
·
Anthony O. Etyang
, Ifedayo Adetifa
, et al.
·
PLOS Global Public Health
·
29
SARS‐CoV‐2 seroprevalence and implications for population immunity: Evidence from two Health and Demographic Surveillance System sites in Kenya, February–December 2022
2023
·
E. Wangeci Kagucia
, Abdhala K. Ziraba
, et al.
·
Influenza and Other Respiratory Viruses
·
25
PDF
Comparative performance of WANTAI ELISA for total immunoglobulin to receptor binding protein and an ELISA for IgG to spike protein in detecting SARS-CoV-2 antibodies in Kenyan populations
2021
·
James Nyagwange
, Bernadette Kutima
, et al.
·
Journal of Clinical Virology
·
24
PDF
Characterization of the Theileria parva sporozoite proteome
2017
·
James Nyagwange
, Edwin Tijhaar
, et al.
·
International Journal for Parasitology
·
23
PDF
Synergistic Effect of Two Nanotechnologies Enhances the Protective Capacity of the Theileria parva Sporozoite p67C Antigen in Cattle
2021
·
Anna Lacasta
, Karishma T Mody
, et al.
·
The Journal of Immunology
·
21
PDF
Learning from serosurveillance for SARS-CoV-2 to inform pandemic preparedness and response
2023
·
Sophie A Müller
, Ambrose Agweyu
, et al.
·
The Lancet
·
16
PDF
Epidemiology of COVID-19 infections on routine polymerase chain reaction (PCR) and serology testing in Coastal Kenya
2022
·
James Nyagwange
, Leonard Ndwiga
, et al.
·
Wellcome Open Research
·
16
PDF
Leveraging the Medicines for Malaria Venture malaria and pathogen boxes to discover chemical inhibitors of East Coast fever
2019
·
James Nyagwange
, Elias Awino
, et al.
·
International Journal for Parasitology Drugs and Drug Resistance
·
15
A Customizable Suite of Methods to Sequence and Annotate Cattle Antibodies
2023
·
Kristel Ramirez Valdez
, Benjamin Nzau
, et al.
·
Vaccines
·
14
PDF
Antibodies to in silico selected GPI-anchored Theileria parva proteins neutralize sporozoite infection in vitro
2018
·
James Nyagwange
, Vishvanath Nene
, et al.
·
Veterinary Immunology and Immunopathology
·
14
PDF
Evaluation of population immunity against SARS-CoV-2 variants, EG.5.1, FY.4, BA.2.86, JN.1, JN.1.4, and KP.3.1.1 using samples from two health demographic surveillance systems in Kenya
2024
·
Doreen Lugano
, Bernadette Kutima
, et al.
·
BMC Infectious Diseases
·
12
PDF
Serum immunoglobulin G and mucosal immunoglobulin A antibodies from prepandemic samples collected in Kilifi, Kenya, neutralize SARS-CoV-2 in vitro
2022
·
James Nyagwange
, Bernadette Kutima
, et al.
·
International Journal of Infectious Diseases
·
11
Metagenomic analysis of coastal Kenya female Aedes aegypti mosquito RNA metaviromes reveal presence of diverse insect specific viruses
2023
·
Donwilliams O. Omuoyo
, Doris K. Nyamwaya
, et al.
·
Wellcome Open Research
·
9
Safety and immunogenicity of ChAdOx1 nCoV-19 (AZD1222) vaccine in adults in Kenya: a phase 1/2 single-blind, randomised controlled trial
2023
·
Mainga Hamaluba
, Samuel Sang
, et al.
·
Wellcome Open Research
·
8
Heart-nosed bat alphacoronaviruses use human CEACAM6 to enter cells
2026
·
Giulia Gallo
, Antonello Di Nardo
, et al.
·
Nature
·
6
Longitudinal Epidemiology and Variant Dynamics of SARS-CoV-2 in Coastal Kenya (2020–2025): Clinical Features and Wave Patterns
2026
·
Arnold W Lambisia
, Joyce Nyiro
, et al.
·
Open Forum Infectious Diseases
·
6
Genomic and clinical epidemiology of SARS-CoV-2 in coastal Kenya: insights into variant circulation, reinfection, and multiple lineage importations during a post-pandemic wave
2025
·
Arnold W. Lambisia
, Esther Nyadzua Katama
, et al.
·
BMC Global and Public Health
·
6
PDF
Show more works
View as search
Works count:
73
Citation count:
981
H-index:
15
I10-index:
21
Year
Topic
Type